Clinical Trial: A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes

U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07032688) titled 'A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes' on June 16.

Brief Summary: The objective of this study is to evaluate the pharmacokinetics and pharmacodynamics of SHR-3167 at steady state in subjects with type 2 diabetes.

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes

Intervention: DRUG: SHR-3167 Injection

SHR-3167 injection.

DRUG: Insulin Degludec Injection

Insulin Degludec injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Published by HT Digital Content Servic...